The Role of Contactin 1 in Cancers: What We Know So Far

Yumei Liang1, Cui Ma2, Fengjuan Li3

  • 1Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China.

Frontiers in Oncology
|November 16, 2020
PubMed

Insights

Contactin 1 (CNTN1), a neuronal glycoprotein, is overexpressed in cancers and linked to poor outcomes. Research highlights CNTN1 as a potential therapeutic target for improving cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancers remain challenging to treat despite diagnostic and therapeutic advancements.
  • Targeted therapy offers promise, necessitating the discovery of novel therapeutic targets.
  • Contactin 1 (CNTN1), a neuronal membrane glycoprotein, has emerged as a significant cancer-related molecule.

Purpose of the Study:

  • To review research on CNTN1's role in various cancers.
  • To elucidate CNTN1's involvement in epithelial-mesenchymal transition and signal transduction pathways.
  • To identify future research directions for CNTN1 as a cancer therapeutic target.

Main Methods:

  • Literature review of studies on CNTN1 in cancer.
  • Analysis of CNTN1 expression in cancer cell lines, tissues, and transgenic models.
  • Examination of CNTN1's association with clinical parameters and its role in cancer progression.

Main Results:

  • CNTN1 overexpression is observed in diverse cancer types and is associated with adverse prognostic factors like lymphatic invasion, metastasis, and advanced TNM stage.
  • CNTN1 influences cancer cell invasion, migration, metastasis, and chemoresistance, partly by promoting epithelial-mesenchymal transition.
  • The precise role of CNTN1 in cancer cell proliferation requires further investigation.

Conclusions:

  • CNTN1 is implicated in multiple facets of cancer progression and metastasis.
  • CNTN1's involvement in key signaling pathways and epithelial-mesenchymal transition suggests its potential as a therapeutic target.
  • Further research into CNTN1's functions may unlock new avenues for cancer therapy.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.8K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
5.8K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.3K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.8K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.1K